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Abstract: Gellan gum is a polysaccharide manufactured
by microbial fermentation of the Sphingomonas paucimobilis
microorganism, being commonly used in the food and
pharmaceutical industry. It can be dissolved in water, and
when heated and mixed with mono or divalent cations,
forms a gel upon lowering the temperature under mild
conditions. In this work, gellan gum hydrogels were
analyzed as cells supports in the context of cartilage regen-
eration. Gellan gum hydrogel discs were characterized
in terms of mechanical and structural properties.
Transmission electron microscopy revealed a quite homo-
geneous chain arrangement within the hydrogels matrix,
and dynamic mechanical analysis allowed to characterize
the hydrogels discs viscoelastic properties upon compres-
sion solicitation, being the compressive storage and loss
modulus of !40 kPa and 3 kPa, respectively, at a
frequency of 1 Hz. Rheological measurements determined
the sol-gel transition started to occur at approximately
368C, exhibiting a gelation time of !11 s. Evaluation of
the gellan gum hydrogels biological performance was
performed using a standard MTS cytotoxicity test,
which showed that the leachables released are not
deleterious to the cells and hence were noncytotoxic.
Gellan gum hydrogels were afterwards used to encapsu-
late human nasal chondrocytes (1 3 106 cells/mL) and
culture them for total periods of 2 weeks. Cells viability
was confirmed using confocal calcein AM staining.
Histological observations revealed normal chondrocytes
morphology and the obtained data supports the claim
that this new biomaterial has the potential to serve as a
cell support in the field of cartilage regeneration.
! 2009 Wiley Periodicals, Inc. J Biomed Mater Res 93A:
852–863, 2010
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INTRODUCTION
Tissue engineering has been proposed as a new
method to address problems such as organ failure
and tissue regeneration, being widely studied nowa-
days as a tool to tackle problems in a diverse range
of tissues.1–4 Such conditions pose serious health
problems, being responsible for a decrease in people
quality of life. Cartilage is one of the most studied
tissues in this field giving the importance it has on
mobility and locomotion. Because of its limited
capacity for self repair, cartilage becomes an enor-
mous constraint to normal everyday life once degen-
erated or traumatized. Structures that can provide
support for specific cells to develop and generate a
functional cartilaginous tissue are an important sub-
ject of study. Different types of natural and synthetic
biomaterials have been processed using different
techniques for this purpose. We are proposing in
this work a new biomaterial-Gellan gum to be used
in the engineering of cartilaginous tissues, even
though its application may not be restricted to this
tissue only, as it will be shown by the different 3D
structures that can be obtained. Recent work per-
formed by Smith et al. has also suggested the use of
this biomaterial for tissue engineering applications.5
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Gellan gum is a linear anionic polysaccharide
composed of tetrasaccharide (1,3-b-D-glucose, 1,4-b-D-
glucuronic acid, 1,4-b-D-glucose, 1,4-a-L-rhamnose)
repeating units, containing one carboxyl side group,
and was initially described by Moorhouse et al.6,7
This material has a broad use in the food industry
and biomedical fields, mostly due to its processing
into transparent gels that are resistant to heat and
acid stress. Two gellan gum forms exist, acetylated
and deacetylated, being the latter the most common
and commercially available form. Both form thermor-
eversible gels, varying in their mechanical properties
from soft and elastic for the acetylated form to hard
and brittle for the fully deacetylated polysaccha-
ride.8,9 Gellan gum can form gels in the following
way: at high temperatures, Gellan gum is in the coil
form; upon temperature decrease, a thermally-
reversible coil to double-helix transition occurs, which
is a prerequisite for gel formation. Afterwards, a
structure composed of anti-parallel double helices self
assembled to form oriented bundles, called junction
zones, is formed. Untwined regions of polysaccharide
chains, in the form of extended helical chains, link the
junction zones, leading to the formation of a three
dimensional network, that creates the gel.10 These
structural changes occurring to gellan gum molecules
have been shown by different techniques. During the
cooling process, for example, rheological and differ-
ential scanning calorimetry (DSC) studies revealed a
first step increase of loss modulus that corresponds to
the coil-helix transition, and a second step increase of
loss modulus due to sol-gel transition.11 The gelation
of gellan gum solutions is strongly influenced by the
chemical nature and quantity of cations present in the
solution. The presence of cations is critical when a
structurally stable gel is to be prepared.10,12,13 In fact,
at low Gellan gum concentrations, the helix formation
and its partial aggregation may form an ordered
structure, but this does not lead to gel formation
because the number of helical aggregates does not
give rise to a continuous network in the whole
volume.11 The main barrier are the carboxyl side
groups that repulse each other by electrostatic interac-
tion, therefore hindering the tight binding of helices
and their cohesive aggregation.9,14–16 The introduc-
tion of cations shields the electrostatic repulsion and
thereby allows the tight binding and aggregation of
helices.11,17,18
The gelation properties of Gellan gum are also
influenced by the nature of the cations used, in
which divalent cations promote the gelation much
more strongly than monovalent cations.11,12 In mono-
valent cations, the gelation is mainly a result of the
screening of the electrostatic repulsion between the
ionized carboxylate groups on the Gellan gum
chains. In the case of divalent cations, the gelation
and aggregation of Gellan occurs via a chemical
bonding between divalent cations and two carboxy-
late groups belonging to glucuronic acid molecules
in the Gellan chains, in adittion to the screening
effect.19 It was also suggested that different types of
mono or divalent cations also influenced the visco-
elastic behavior of Gellan gum solutions. Kþ was
more remarkable than Naþ, and Ca2þ more than
Mg2þ.11 Gellan gum structures have excellent heat
resistance properties because the formed junctions
upon gelation can only be unzipped on heating at
1208C.11 In the initial state, a junction zone in Gellan
gum is estimated to be four double helices wide and
five repeat units long, its length being increased to
seven repeat units upon annealing.10 In the solid
state, the double helix structure adopted by Gellan
gum has a similar arrangement to the double helix
structure of iota carrageenan.20 Previous studies
indicate that solutions of deacetylated gellan gum
behave as a pseudoplastic liquids, as evidenced by
creep testing, and have little thixotropy.13 Gellan
gum advantageous use in the context of biomedical
applications includes its lack of toxicity, processing
under mild conditions, the ability to used as an
injectable system in a minimally invasive manner,
and also the structural similarity it presents with
native cartilage glycosaminoglycans by the presence
of glucuronic acid residues in their repeating
unit.21,22 The presence of this carbohydrate residue,
which contains carboxylic groups, may confer added
functions to this material. Some intellectual property
associated with the application of this material in the
medical field has already been disclosed, as its use
for ophthalmologic purposes.23,24
This work tested for the first time gellan gum as a
new biomaterial to be used in cartilage regeneration
approaches. As shown here, gellan gum hydrogels
are quite versatile in terms of processing and its
materials properties reveal good prospects for their
use as a cell encapsulating agents. Biological evalua-
tion of their cytotoxicity and in vitro culturing of
human nasal chondrocytes generated interesting
results indicating that this new biomaterial may play
a potential role in cartilage regeneration approaches.
MATERIALS AND METHODS
Versatility of Gellan gum: Processing into
different structures (discs, membranes, fibers,
particles, scaffolds)
Note: Unless otherwise stated the reagents were
purchased from Sigma-Aldrich.
Gellan gum (G1910, Sigma, St. Louis, MO) was
processed in different ways giving rise to various struc-
tures, therefore evidencing the versatility of this natural bio-
material. The processing involved temperature-dependent
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and pH-dependent reactions. Regarding gellan gum discs
and membranes production, the following methodology
was used. Gellan gum powder was mixed with distilled
water under constant stirring at room temperature to obtain
a final concentration of 0.7% (w/v). The solution was
progressively heated to 908C, under which complete and
homogeneous dispersion of the material was obtained. The
solution was kept at this temperature during 20–30 min.
Afterwards, CaCl2 (Merck, DE) was added to obtain a final
concentration of 0.03% (w/v) in the gellan gum solution
and the temperature was progressively decreased to 508C.
Gellan discs were produced by casting the solution into
cylindrical moulds and allowing it to rest at room tempera-
ture for 2–5 min and form a solid gel. The discs were then
cut using a borer for final discs dimensions of Ø 6 6 0.01
mm 3 5.5 6 0.46 mm height. Gellan gum membranes were
produced by casting the solution into Petri dishes and
allowing it to stand at room temperature for 2–5 min and
form a solid gel. The Petri dishes were kept in an oven at
378C for 90 min. Concerning the production of Gellan gum
fibers and particles the methodology was as follows. Gellan
gum powder was mixed with a NaOH 0.10M solution and
stirred at room temperature with a final concentration of
4% (w/v). Gellan gum fibers were produced by extruding
the gellan gum solution into a L-ascorbic acid 20% (v/v)
solution under a constant flow rate of 0.2 mL/min, using a
21G needle. The gellan gum fibers formed were then
washed in distilled water, pressed into cylindrical moulds,
and dried overnight at 378C. Gellan gum particles were
produced by extruding the Gellan gum 4% (w/v) solution
dropwise to an L-ascorbic acid 20% (v/v) solution under a
constant flow rate of 0.8 mL/min, using a 21G needle.
Gellan gum scaffolds were produced by immersing gellan
gum 0.7% (w/v) (Ø 6 6 0.01 mm 3 5.5 6 0.46 mm height)
discs in liquid nitrogen for 1–2 min and quickly transferring
them to a lyophilizator (Telstar Cryodos-80, Telstar, Spain)
where they were lyophilized during 2 days. Lyophilized
gellan gum 0.7% discs were further analyzed under micro-
computed tomography (l-CT) using a high-resolution l-CT
Skyscan 1072 scanner (Skyscan, Kontich, Belgium) using a
resolution of 6.76 lm pixel size and integration time of 1.7
ms. The X-ray source was set at 70 keV of energy and 142
lA of current. Approximately 500 projections were acquired
over a rotation range of 1808 and a rotation step of 0.458.
Data sets were reconstructed using standardized cone-beam
reconstruction software (NRecon v1.4.3, SkyScan). The out-
put format for each sample was a 500 serial of 1024 3 1024
bitmap images. Representative data sets of 150 slices were
segmented into binary images (CT Analyser, v1.5.1.5, Sky-
Scan) with a dynamic threshold of 70–255 (gray values) that
was applied to build the 3D models. 3D virtual models
(height 1 mm 3 Ø 3 mm) of representative regions in the
bulk of the hydrogels were created, visualized, and regis-
tered using image processing software (CT Analyser,
v1.5.1.5 and ANT 3D creator, v2.4, both from SkyScan).
Transmission electron microscopy
Gellan gum discs were prepared for transmission mi-
croscopy analysis in the following way. Briefly, sections of
1 mm3 were fixed in formalin-glutaraldehyde-osmium
tetroxide for 2 h at room temperature and then washed
3 times in PBS. Semithin sections (1 lm) were cut from
epon-embedded blocks and stained with toluidine blue.
Ultrathin sections (600 A˚) were cut in a ultratome (Reichert
Ultranova Leica), mounted onto copper grids, stained with
uranyl acetate (7 min) and lead citrate (5 min), and
observed on a Zeiss 902A (50 Kv) electron microscope.
Dynamic mechanical analysis
Dynamic mechanical analysis (DMA) was conducted to
characterize the mechanical behavior of Gellan gum hydro-
gel discs. Gellan gum 0.7% (w/v) discs (Ø 6 6 0.01 mm 3
5.5 6 0.46 mm height) discs were subjected to compression
cycles of increasing frequencies ranging from 0.1 to 10 Hz
with constant amplitude displacements of 0.1 mm using a
Tritec 2000 DMA (Triton Technology, UK). Storage and
loss modulus were measured and experiments were
conducted at room temperature. The total number of discs
per assay were n 5 3. The described values for the com-
pression modulus were collected at a frequency of 1 Hz.
Statistical analysis was performed using confidence inter-
vals based on the experimental results, with a confidence
level of 99%.
Rheological studies
Cone-Plate rheometry was conducted for gellan gum
hydrogels in order to assess their rheological behavior
dependence of temperature and time. For this purpose,
gellan gum powder was mixed at room temperature with
distilled water at a concentration of 0.7% (w/v) under
constant stirring. The solution was heated to 908C and
kept at this temperature for 30 min. Afterwards, CaCl2
was added to the Gellan gum solution at concentration of
0.03% (w/v) and rheological measurements were per-
formed using a controlled stress cone-plate rheometer
(Reometer Reologica, StressTech, Sweden). For each mea-
surement, a volume of 2 mL of the Gellan gum solution
was placed in the bottom plate of the rheometer and
held at a constant temperature of 708C. The polymer so-
lution was allowed to rest for 1 min before starting the
experiments. Measurements were performed by cooling
each sample from 708C to 258C (at a cooling rate of
268C/min) applying a constant shear stress of 0.1 Pa.
Temperature, time, shear rate, and viscosity were con-
stantly measured. The total number of repeats was n 5 3
and confidence intervals were estimated, with a confi-
dence level of 99%.
Cytotoxicity evaluation
To assess the possible cytotoxicity of the processed
gellan gum hydrogels, MTS (3-(4,5-dimethylthiazol-2-yl)-
5(3-carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium)
test was used according to ISO/EN 10993 part 5 guide-
lines, which determines whether cells are metabolically
active.25 This cytotoxicity test is based on the bioreduc-
tion of the substrate, 3-(4,5-dimethylthiazol-2-yl)-5(3-
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carboxymethoxyphenyl)-2(4-sulfofenyl)-2H-tetrazolium
(MTS) (Cell Titer 961 Aqueous Solution Cell Proliferation
Assay, Promega), into a brown formazan product by dehy-
drogenase enzymes in metabolically active cells, and is
commonly used for cell viability evaluation. Latex rubber
was used as positive control for cell death, due to its high
cytotoxicity to cells, and culture medium was used as a
negative control. A rat lung fibroblasts cell line-L929,
acquired from the European Collection of Cell Cultures
(ECACC), was used for the studies. The cells were grown
as monolayers in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% foetal bovine serum (Bio-
chrom, Berlin, Germany; Heat Inactivated) and 1% of anti-
biotic-antimycotic mixture.
The gellan gum hydrogel discs were incubated in
culture medium for 24 h at 378C with constant shaking,
as well as latex. Cultured L929 cells were trypsinized
using trypsin-EDTA (Gibco, Invitrogen Corporation) and
plated at a density of 6.6 3 104 cells/well into 96-well
micrometer plates (200 lL/well). The plates were incu-
bated for 24 h at 378C in a humidified atmosphere of
5% CO2 in air. Afterwards, the medium was replaced
by the extracts previously obtained, using culture me-
dium as a negative control. After 72 h, the cell culture
was incubated with MTS (using culturing medium with-
out phenol red) for further 3 h at 378C in a humidified
atmosphere of 5% CO2 in air. Culture medium with
MTS was then transferred to new wells. The optical
density (OD) which is directly proportional to the cellu-
lar activity, being a measure of mitochondrial acitivity,
was read on a multiwell microplate reader (Synergy HT,
Bio-TeK Instruments) at 490 nm. Statistical analyses were
conducted using a two-sample t-test assuming unequal
variances for n 5 3.
Isolation and expansion of human
nasal chondrocytes
Nasal cartilage was harvested from the nasal septum
of adult patients (40–65 years) undergoing reconstructive
surgery. This was performed within the scope of a proto-
col established with the Hospital de S. Marcos, Braga,
Portugal, approved by its Ethical Committee and always
sampled upon patient informed consent. The human
nasal septum cartilage free from all surrounding tissue
was placed in a Petri dish containing sterile phosphate
buffered saline (PBS) and cut into square slices of 5 mm
and thickness between 2–3 mm. The pieces were washed
in sterile PBS solution, immersed in 20 mL of trypsin-
EDTA solution, and incubated for 30 min at 378C on a
rotator. Trypsin was removed and the pieces washed
with basic DMEM. Then, 20 mL of filter sterilized colla-
genase type II solution (2 mg/mL) in basic medium was
added, and the mixture incubated for !12 h at 378C on a
rotator. The digested tissue and cell suspension solution
was centrifuged at 200g for 7 min and the supernatant
removed. The cell pellet was washed with PBS and the
cells centrifuged as before. The procedure was repeated
and the cells were ressuspended in PBS and counted
using a hemocytometer. They were again centrifuged, the
supernatant removed, and ressuspended in expansion
medium consisting of Dulbecco’s Modified Eagle’s
Medium, containing 10 mM HEPES buffer pH 7.4, 10,000
units/mL penicillin/10,000 lg/mL streptomycin, 20 mM
L-alanyl glutamine, 13 MEM nonessential amino acids,
and 10% (v/v) foetal bovine serum (FBS; Biochrom, Berlin,
Germany; Heat Inactivated), supplemented with 10 ng/mL
basic fibroblast growth factor (bFGF) (PeproTech, UK).
Human nasal chondrocytes were plated into tissue culture
flasks and incubated at 378C in a humidified atmosphere of
5% CO2 in air for expansion.
26
Human nasal chondrocytes encapsulation in gellan
gum and agarose hydrogels
Human nasal chondrocytes were expanded until an
adequate cell number was obtained for cells encapsulation.
Cells were encapsulated at passage 1 in gellan gum hydro-
gels and in agarose type VII (A6560; Sigma, St. Louis, MO)
hydrogels, the latter being used as controls.
Regarding gellan gum the procedure was the follow-
ing. Gellan gum powder was mixed with sterile distilled
water under constant stirring at room temperature to
obtain a final concentration of 0.7% (w/v). The solution
was progressively heated to 908C and kept at this tem-
perature for 20–30 min. A sterile CaCl2 solution was
added to obtain a final concentration of 0.03% (w/v). The
temperature was progressively decreased to 408C and
stabilized at this stage always under constant stirring.
Human nasal chondrocytes were detached by trypsiniza-
tion, mixed with expansion medium, and centrifuged at
200g for 7 min. The supernatant was removed and the
cells were ressuspended in warm sterile PBS solution,
counted using and hemocytometer, and finally centri-
fuged at 200g for 7 min. The supernatant was discarded
and the cells pellet kept at the bottom of the falcon tube.
The gellan gum 0.7% (w/v) with CaCl2 0.03% (w/v)
solution was added to the cells pellet and the mixture
ressuspended for complete homogenization of cells within
the matrix with a final concentration of 1 3 106 cells/mL.
Gellan discs with encapsulated human nasal chondrocytes
were produced by casting this mixture into sterile cylin-
drical polystyrene moulds, allowing it to rest at room
temperature for 1–2 min to form a solid gel, and then
discs of Ø 6 6 0.01 mm 3 5.5 6 0.46 mm height were
cut using a borer.
Regarding the agarose hydrogels, the procedure is
detailed elsewhere.27 Briefly, a sterile agarose type VII low
Tm 4% (w/v) solution prepared in sterile PBS was heated
to 708C for 30 s, until complete dissolution. The solution
was stabilized at 408C and added to a human nasal chon-
drocytes pellet prepared as described for the gellan gum
encapsulation and the mixture ressuspended for complete
homogenization of cells within the matrix with a final
concentration of 1 3 106 cells/mL. Agarose discs with
encapsulated human nasal chondrocytes were produced
by casting this mixture into sterile cylindrical polystyrene
moulds, allowing it to rest at room temperature for 20 min
to form a solid gel, and then discs were cut using a borer.
Both gellan gum and agarose hydrogels with encapsulated
cells were cultured for 2 weeks with expansion medium
under orbital rotation (50 rpm). Afterwards, expansion
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medium was replaced for 6 weeks by differentiation
medium to promote the formation of a chondrogenic phe-
notype. This medium presents the same composition as
the expansion medium except for the bFGF which is
replaced with 1 lg/mL of insulin and 50 lg/mL of
L-ascorbic acid. The cells-hydrogel systems were returned
to the orbital shaker and the culture medium was replaced
every 2–3 days. The experiments were repeated three times
independently.
Human nasal chondrocytes encapsulated in gellan
gum and agarose hydrogels: Cell viability tests and
histological analysis
Human nasal chondrocytes morphology in the two
hydrogels used, gellan gum and agarose, was observed at
2 weeks of culture under optical microscopy. One
representative sample of each type of support was
observed at different magnifications using an optical
microscope (Axiovert 40 CFL, Zeiss).
Cells viability at 2 weeks of culturing was assessed
using calcein AM staining. Calcein AM (C3099, Invitrogen
Corp.) is a fluorescence-based method for assaying cell via-
bility and cytotoxicity in which the reagent is retained in
cells that have intact membrane. Briefly, a calcein AM so-
lution of 1/1000 was prepared in culture medium. One
disc of each type of hydrogel with encapsulated human
nasal chondrocytes was collected from the culturing plates
and incubated in the calcein AM solution for 15–30 min at
378C and afterwards washed in sterile PBS. The samples
were observed under fluorescent microscopy (Zeiss HAL
100/HBO 100; Axiocam MRc5 (Zeiss)).
Concerning the histological analysis, hematoxylin-eosin
and alcian blue staining were performed on 8 lm thick-
ness sections of gellan gum and agarose discs collected at
2 weeks of culture using in-house methodology. The discs
were fixated by immersion for 30–40 min in glutaralde-
hyde 2.5% (v/v) at 48C, and washed in PBS. Histological
processing was performed using Tecnhovit 71001
(Heraeus Kulzer GmbH, DE) and the technical details and
procedure can be found in the commercial package. Sec-
tions were cut using a microtome Leica RM2155 (Leica
Microsystems, Nusslock GmbH).
RESULTS AND DISCUSSION
Versatility of Gellan gum: Processing into
different structures (discs, membranes, fibers,
particles, scaffolds)
Gellan gum was processed into different shapes as
shown in Figures 1 and 2. By using simple process-
ing methodologies, involving temperature-dependent
gelation (discs, membranes, scaffolds) [Fig. 2(A,B,E,F)]
and pH-dependent gelation (fibers and particles)
[Fig. 2(C,D)], all those structures were produced. This
shows the versatility of this material to obtain differ-
ent geometrical forms that can be used in a broad
range of tissue engineering and drug delivery appli-
cations. Gellan gum hydrogels can be used to encap-
sulate cells and serve as supports for their develop-
ment. Gellan gum can also be processed into fibers
and generate a 3D structure onto which cells can be
seeded and stimulated to proliferate, an approach
that may also be explored by using membranes. A
gellan gum solution, in which a specific drug is dis-
persed, can be processed into particles such as those
shown in Figure 2(D) and used as a carrier for drug
delivery applications. In fact, gellan gum has been
used previously as an ocular drug delivery sys-
tem.28–30 Different parameters such as temperature,
pH, polymer concentration, and ions nature can be
adjusted to possibly improve the biological perform-
ance or confer certain functionality. The control of
the sol-gel transition at physiological temperature
and pH31–33 renders this material the possibility to
be used as an injectable system, which is a highly
recommended approach in several situations.34 The
most relevant factor in the hydrogel forming ability
of gellan gum is the presence of D-glucuronic acid
molecules in the tetrasaccharide repeating unit of the
polysaccharide. These monosaccharides possess car-
boxylic groups in their structure that form internal
hydrogen bonds and stabilize the double helices.
Figure 1. Sol-gel transition occurring in a Gellan gum solution containing CaCl2.
856 OLIVEIRA ET AL.
Journal of Biomedical Materials Research Part A
Nevertheless, carboxyl side groups that repulse each
other by electrostatic interaction, hinder the tight
binding of helices and their cohesive aggregation,
affecting the formation of stable gels. The mono or
divalent ions present in the solution play a key role
in this matter. Their presence diminishes the repul-
sive energy between the carboxylic groups allowing
the hydrogels to be formed. The variation in pH also
affects the solubility of the material being this the
main factor in the processing of gellan gum fibers
and particles [Fig. 2(C,D)]. At a basic pH, such as
the NaOH solution used in the experiments, the car-
boxylic groups present in each D-glucuronic acid res-
idue should be in the anionic form, COO2, and
therefore soluble in solution. Once the pH is low-
ered, as upon extrusion into an L-ascorbic acid solu-
tion, the carboxylic groups become protonated,
COOH, and the material turns insoluble.
Transmission electron microscopy
Transmission electron microscopy (TEM) was
performed to have an insight on the ultrastructural
morphology of the gellan gum hydrogels (Fig. 3). As
described before for the gel state, gellan gum hydro-
gels constitute a matrix where double helices that
originated from the coil form rearrangement in solu-
tion are widely present and distributed in a rather
homogeneous fashion.35 These give rise to junction
zones by linking to a neighbor double helical mole-
cule. The overall stability of the hydrogel network
derives from the loose ends within the double helical
molecules. These, together with the cationic anti
repulsive effect allow obtaining a stable hydrogel
when the temperature is decreased below the setting
point. Previous work has already used TEM as a
Figure 2. The versatility of Gellan gum structures that can be formed using simple polymer processing technologies:
(A) discs; (B) membranes; (C) fibers; (D) particles; (E) and (F) 3D lyophilized scaffolds.
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tool to characterize the ultrastructural properties of
gellan-based hydrogels.36 The authors showed
that gellan gum forms strong gels at low ionic
concentrations, being these highly homogeneous and
constituted by a dense fibrous network structure. The
work presented here confirmed this, being observed
that gellan gum hydrogels provide a uniform matrix
at a nanoscale throughout which cells could be encap-
sulated in a rather homogeneous way (Fig. 3).
Dynamic mechanical analysis
Living tissues exhibit clear viscolelastic properties
and therefore it is important to characterize the
solid-state rheological features of materials that are
meant to be in contact with them. DMA has been
used in our group to assess the viscoelastic proper-
ties of biomaterials, including natural-based hydro-
gels or highly hydrated systems.37–40 In this work,
gellan gum hydrogels were analyzed in the wet state
throughout a physiological relevant frequency range.
Both the storage (elastic) and loss (viscous) compo-
nents of the complex modulus are shown in Figure
4. The storage modulus (E0) is about one order of
magnitude higher than the loss modulus (E@) indi-
cating a clear elastic nature of the gel. However, it
possesses some damping capability that may be use-
ful to dissipate some cyclic mechanical energy that is
imposed in an implantation scenario. Although some
increase in E0 is observed for increasing frequencies,
the elastic properties of the biomaterial are quite sta-
ble, when compared with the viscous component. In
fact, a clear increase in E@ is observed between 0.4
and 10 Hz, which suggests that the material exhibits
higher dissipation capability for high frequencies. At
a frequency of 1 Hz, the compression modulus of
the gels was estimated to be of 38.3 6 6.3 kPa [38.2,
38.4 t(0.01,2)] at room temperature. Even though this
value is not optimal in terms of mimicking human
articular cartilage mechanical properties,41 it is
higher or within the range of values found for
hydrogels used in similar cartilage regenerative
approaches.42,43 The gellan gum support is conceived
in this initial work to serve as a cell support due to
its features, even though it may be optimized for
being applied as an injectable system.31–33 Cells
encapsulation and extracellular matrix deposition
may result in progressive increase of the mechanical
properties of the 3D structures, as shown before for
other systems.42
Rheological Studies
Rheological measurements were performed to
determine the temperature range at which the
Figure 3. Transmission electron microscopy micrograph
of a Gellan gum hydrogel showing a dense and homoge-
neous network structure at the ultrastructural level.
Figure 4. Dynamic mechanical analysis of Gellan gum
hydrogels showing the storage (E0) and loss (E@) modulus
upon compression solicitation using different frequencies.
Figure 5. Rheological measurements of Gellan gum solu-
tions. The upper x axis shows the relation between temper-
ature and viscosity, while the bottom x axis shows the
relation between time-length and viscosity.
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sol-gel transition occurred and the time-scale for gel-
ling. Regarding gelation temperature, it is possible
to state from the rheological measurements that
it happens around 378C (36.6 6 0.058C) [36.586,
36.588 t(0.01,2)] (Fig. 5).
Concerning the time-scale for gelling, it is possible
to observe from the graph on Figure 5 that it is of
!11 s (11.27 6 0.40 s) [11.258, 11.275 t(0.01,2)]. The
results obtained for both temperature and time of
gelation provide important information concerning
subsequent experiments for cells encapsulation. The
temperature at which the sol-gel transition occurs,
and the overall residence time, is similar to other
hydrogels used for the same purpose.27,44 Gellan gum
hydrogels allowed for a homogeneous cell suspension
to be prepared at a temperature above the setting
temperature of the gels. At such temperatures, the
viscosity of the solution presents values near to zero,
which enable it to be mixed with the cells, ressus-
pended to generate a uniform cells distribution, and
then lower the temperature to allow gel formation
and cells entrapment within the newly formed ma-
trix. The quick gelling time may be useful in the use
of gellan gum as an injectable system that could
deliver cells through a minimally invasive procedure,
although these kinetics can be modified.
Cytotoxicity evaluation
The MTS cytotoxicity test results showed that the
gellan gum hydrogels did not cause any deleterious
alteration to the metabolic activity of L929 cells and
thus, were considered as noncytotoxic (Fig. 6). The
results were comparable to those obtained with tis-
sue culture polystyrene (TCPS), which was used as
the negative control for cell death (differences are
not statistically significant). The toxic effect of the
positive control for cell death (latex) was clear, given
the severe decrease on cell viability shown on the
graph (Fig. 6).
Human nasal chondrocytes encapsulated in gellan
gum and agarose hydrogels: Cell viability tests and
histological analysis
Figure 7(A,B) show the human nasal chondrocytes
efficiently encapsulated in the gels. This result is
extremely important if the aim of the gellan gum
supports is their use as cells encapsulating agents to
be used in cartilage regeneration approaches. In fact,
it is known that anchorage independent cells like
chondrocytes exhibit good cell viability within
hydrophilic scaffolds like hydrogels, and studies
Figure 6. MTS cytotoxicity test performed to evaluate the
possible cytotoxic effects of the leachables released by the
gellan gum hydrogels. Results show the gels are noncyto-
toxic.
Figure 7. Optical microscopy images of human nasal chondrocytes encapsulated in gellan gum (A) and agarose (B) at 2
weeks of culture. The formation of human chondrocytes clusters was observed in gellan gum hydrogels (A, arrows).
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using human nasal chondrocytes revealed that this
hydrophilicity facilitated the redifferentiation of
de-differentiated chondrocytes.34 This evidence
opens interesting prospects for the performance of
these new supports in cartilage regeneration along
with the rather homogeneous distribution of the
chondrocytes throughout the gellan gum hydrogels
matrix (Fig. 7), which showed a round-shaped
morphology typically present in the native human
cartilaginous tissue. An interesting result was
observed in gellan gum but not in agarose. In the
first, the formation of chondrocytes clusters was fre-
quently observed near 2 weeks of culture [Fig. 7(A)],
a feature that was not noticed on the early periods
of culture. Such structures may be indicative of cell
proliferation in these clusters which may give a posi-
tive contribution towards the production of a hya-
line-like cartilage matrix45–47 The cells may use the
gellan gum as a source of carbohydrates due to its
polysaccharidic nature, a fact that may be even more
interesting to study in an in vivo scenario. The
scenario of cells using the matrix as a source of
energy is possible although such hypothesis demand
proper validation testing. Also, the formation of the
chondrocytes clusters has been previously described
in the literature as osteoarthritis related events.47,48
This seems however unlikely because no typically
hypertrophic cells with increased cell size were
observed, but these assumptions should be con-
firmed in further studies.
Calcein AM fluorescence-based method was con-
ducted to confirm chondrocytes viability. Results
from samples collected after 2 weeks of culture are
presented on Figure 8 showing the cells were viable
in both hydrogels. These are also indicative of the
adequacy of gellan gum for cartilage regeneration,
because no apparent difference is noticeable when
compared to agarose hydrogels.
Concerning the histological analysis, it is clear
from the images that cells distribution within the
two supports are similar, presenting uniform distri-
bution and active states of division (Fig. 9, arrows).
This indicates that gellan gum allowed adequate
chondrocytes encapsulation while its network matrix
permits cells to encompass active division. More-
over, alcian blue staining indicates that proteogly-
cans are being deposited to a small extent in the
pericellular regions of some groups of cells, while
maintaining the typical chondrocyte round-shaped
phenotype (Fig. 10, arrows).
The data collected so far with gellan gum hydrogels
showed that they possess suitable materials proper-
ties to be used as supports for chondrocytes develop-
ment, such as the gelling at physiological conditions
and their tested noncytotoxicity. Furthermore, they
were able to efficiently encapsulate human nasal
chondrocytes with a homogeneous distribution and
maintain their viability for at least 2 weeks of culture.
The overall data analysis suggests that this new
biomaterial can have a high potential application in
cartilage regeneration approaches and work is
ongoing to further corroborate this hypothesis.
Another aspect to look into is their potential use for
other types of tissues or strategies, given its versatility
in terms of processing and materials properties.
CONCLUSIONS
In this work, gellan gum has been presented as a
new biomaterial for cartilage tissue engineering
Figure 8. Calcein AM viability test of human nasal chondrocytes encapsulated in gellan gum (A) and agarose
(B) hydrogels at 2 weeks of culture.
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approaches. Gellan gum was shown to be very
versatile in terms of processing, which can be
controlled by both temperature and pH, forming
structures with different shapes using simple polymer
processing technologies. Discs, membranes, fibers,
particles, and scaffolds were produced demonstrating
the range of possible applications for this biomaterial.
These may range from cell encapsulation technologies
to drug delivery strategies, for example. An extensive
characterization of Gellan gum discs to be used as cell
supports indicated that they are suitable for fulfilling
such functions, since a solution combining nonharsh
reagents (gellan gum, calcium chloride and water) can
be prepared, mixed uniformly with human nasal
chondrocytes, and gelled near the body temperature
in few seconds, enabling a high cell entrapment yield
and homogeneous distribution. Gellan gum hydrogels
presented viscoelastic properties within the range of
other hydrogels used for cells encapsulation42,43 and
were shown to be noncytotoxic. Calcein AM staining
showed cells were viable during the time of the
experiments. Hematoxylin-eosin staining revealed
that active cells division was occurring and alcian blue
staining indicated that extracellular matrix compo-
nents are being deposited to a small extent in some
pericellular regions.
Figure 9. Hematoxylin-eosin staining of histological sections of gellan gum (A) and agarose (B) hydrogels at 2 weeks of
culture. Human nasal chondrocytes present a typical round-shaped morphology and active cell division can be observed
in both supports (arrows).
Figure 10. Alcian blue staining of histological sections of gellan gum (A) and agarose (B) hydrogels at 2 weeks of culture.
Proteoglycans were detected in some pericellular regions in both supports (arrows).
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